Debt-to-equity of Aldeyra Therapeutics, Inc. from 30 Sep 2014 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aldeyra Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 31 Dec 2025.
  • Aldeyra Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 54%, a 65% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Aldeyra Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 54% +21% +65% 31 Dec 2025
Q3 2025 51% +23% +82% 30 Sep 2025
Q2 2025 45% +22% +91% 30 Jun 2025
Q1 2025 39% +17% +77% 31 Mar 2025
Q4 2024 33% +12% +54% 31 Dec 2024
Q3 2024 28% +7.4% +36% 30 Sep 2024
Q2 2024 24% +4.1% +21% 30 Jun 2024
Q1 2024 22% +3.4% +18% 31 Mar 2024
Q4 2023 21% +4.2% +25% 31 Dec 2023
Q3 2023 21% +5% +32% 30 Sep 2023
Q2 2023 20% +5.3% +37% 30 Jun 2023
Q1 2023 19% +5.6% +44% 31 Mar 2023
Q4 2022 17% +4.6% +37% 31 Dec 2022
Q3 2022 16% +0.62% +4.1% 30 Sep 2022
Q2 2022 14% -3.4% -19% 30 Jun 2022
Q1 2022 13% -14% -52% 31 Mar 2022
Q4 2021 13% -24% -65% 31 Dec 2021
Q3 2021 15% -25% -62% 30 Sep 2021
Q2 2021 18% -30% -62% 30 Jun 2021
Q1 2021 27% -11% -29% 31 Mar 2021
Q4 2020 36% +7.5% +26% 31 Dec 2020
Q3 2020 40% +22% +120% 30 Sep 2020
Q2 2020 47% +35% +272% 30 Jun 2020
Q1 2020 38% +24% +167% 31 Mar 2020
Q4 2019 29% +14% +92% 31 Dec 2019
Q3 2019 18% +0.93% +5.4% 30 Sep 2019
Q2 2019 13% +0.73% +6.1% 30 Jun 2019
Q1 2019 14% +3.4% +31% 31 Mar 2019
Q4 2018 15% +4.3% +40% 31 Dec 2018
Q3 2018 17% +5.8% +51% 30 Sep 2018
Q2 2018 12% -1.9% -14% 30 Jun 2018
Q1 2018 11% -2.4% -18% 31 Mar 2018
Q4 2017 11% -3% -22% 31 Dec 2017
Q3 2017 11% -1.7% -13% 30 Sep 2017
Q2 2017 14% +2.1% +18% 30 Jun 2017
Q1 2017 13% +2.7% +25% 31 Mar 2017
Q4 2016 14% +3.1% +30% 31 Dec 2016
Q3 2016 13% +1.1% +9% 30 Sep 2016
Q2 2016 12% -3.3% -22% 30 Jun 2016
Q1 2016 11% -12% -53% 31 Mar 2016
Q4 2015 11% +80% 31 Dec 2015
Q3 2015 12% +34% 30 Sep 2015
Q2 2015 15% 30 Jun 2015
Q1 2015 23% 31 Mar 2015
Q4 2014 -69% 31 Dec 2014
Q3 2014 -22% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.